707 related articles for article (PubMed ID: 9015216)
1. Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils.
Avalos BR; Parker JM; Ware DA; Hunter MG; Sibert KA; Druker BJ
Exp Hematol; 1997 Feb; 25(2):160-8. PubMed ID: 9015216
[TBL] [Abstract][Full Text] [Related]
2. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor.
Shimoda K; Feng J; Murakami H; Nagata S; Watling D; Rogers NC; Stark GR; Kerr IM; Ihle JN
Blood; 1997 Jul; 90(2):597-604. PubMed ID: 9226159
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route.
Barge RM; de Koning JP; Pouwels K; Dong F; Löwenberg B; Touw IP
Blood; 1996 Mar; 87(6):2148-53. PubMed ID: 8630373
[TBL] [Abstract][Full Text] [Related]
4. Point mutations in the conserved box 1 region inactivate the human granulocyte colony-stimulating factor receptor for growth signal transduction and tyrosine phosphorylation of p75c-rel.
Avalos BR; Hunter MG; Parker JM; Ceselski SK; Druker BJ; Corey SJ; Mehta VB
Blood; 1995 Jun; 85(11):3117-26. PubMed ID: 7538818
[TBL] [Abstract][Full Text] [Related]
5. Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases.
Dong F; Larner AC
Blood; 2000 Mar; 95(5):1656-62. PubMed ID: 10688821
[TBL] [Abstract][Full Text] [Related]
6. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK.
Nicholson SE; Novak U; Ziegler SF; Layton JE
Blood; 1995 Nov; 86(10):3698-704. PubMed ID: 7579336
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
8. G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses.
Zhu QS; Robinson LJ; Roginskaya V; Corey SJ
Blood; 2004 May; 103(9):3305-12. PubMed ID: 14656892
[TBL] [Abstract][Full Text] [Related]
9. The granulocyte colony stimulating factor (G-CSF) activates Jak/STAT and MAPK pathways in a trophoblastic cell line.
Marino VJ; Roguin LP
J Cell Biochem; 2008 Apr; 103(5):1512-23. PubMed ID: 17879956
[TBL] [Abstract][Full Text] [Related]
10. Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation.
Wang L; Rudert WA; Loutaev I; Roginskaya V; Corey SJ
Oncogene; 2002 Aug; 21(34):5346-55. PubMed ID: 12149655
[TBL] [Abstract][Full Text] [Related]
11. Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors.
Monahan JB; Hood WF; Welply JK; Shieh JJ; Polazzi JO; Li X
Exp Hematol; 2001 Apr; 29(4):416-24. PubMed ID: 11301181
[TBL] [Abstract][Full Text] [Related]
12. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Selective activation of Jak2, Stat3, and Stat5b.
Al-Shami A; Mahanna W; Naccache PH
J Biol Chem; 1998 Jan; 273(2):1058-63. PubMed ID: 9422769
[TBL] [Abstract][Full Text] [Related]
14. Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor.
Tian SS; Lamb P; Seidel HM; Stein RB; Rosen J
Blood; 1994 Sep; 84(6):1760-4. PubMed ID: 7521688
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
16. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes.
Tian SS; Tapley P; Sincich C; Stein RB; Rosen J; Lamb P
Blood; 1996 Dec; 88(12):4435-44. PubMed ID: 8977235
[TBL] [Abstract][Full Text] [Related]
17. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.
Park ES; Kim H; Suh JM; Park SJ; You SH; Chung HK; Lee KW; Kwon OY; Cho BY; Kim YK; Ro HK; Chung J; Shong M
Mol Endocrinol; 2000 May; 14(5):662-70. PubMed ID: 10809230
[TBL] [Abstract][Full Text] [Related]
18. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
19. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
[TBL] [Abstract][Full Text] [Related]
20. The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation.
de Koning JP; Dong F; Smith L; Schelen AM; Barge RM; van der Plas DC; Hoefsloot LH; Löwenberg B; Touw IP
Blood; 1996 Feb; 87(4):1335-42. PubMed ID: 8608222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
